Literature DB >> 2999142

The effects of processing inhibitors of N-linked oligosaccharides on the intracellular migration of glycoprotein E2 of mouse hepatitis virus and the maturation of coronavirus particles.

R Repp, T Tamura, C B Boschek, H Wege, R T Schwarz, H Niemann.   

Abstract

We have studied the effects of tunicamycin and inhibitors of the processing of N-linked glycans including N-methyl-1-deoxynojirimycin, castanospermine, mannodeoxynojirimycin, and swainsonine on the transport of glycoprotein E2 and the intracellular maturation of the coronavirus mouse hepatitis virus A59. Indirect immunofluorescence staining with monoclonal antibodies revealed that glycoprotein E2 exhibits different antigenic properties depending on the presence and on the structure of the N-linked oligosaccharides and that efficient transport of glycoprotein E2 to the plasma membrane requires the removal of glucose residues. In the presence of tunicamycin in the nonglycosylated E2 apoprotein was synthesized in normal amounts and readily acylated throughout the infectious cycle. This E2-species could not be detected on the surface of mouse hepatitis virus A59-infected cells with indirect immunofluorescence staining or lactoperoxidase labeling. N-Methyl-1-deoxynojirimycin and castanospermine, both of which selectively inhibited the processing glucosidases, caused a drop in virion formation by two log steps and a drastic delay in the surface expression of glycoprotein E2. The E2 species synthesized under such conditions was acylated but accumulated intracellularly in a compartment distinct from the Golgi. Concomitantly, synthesis of the matrix glycoprotein E1 of mouse hepatitis virus A59 was drastically impaired. Mannodeoxynojirimycin and swainsonine, which block later stages of the processing pathway, had less or no effect on the transport of glycoprotein E2 and the formation of virus particles.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999142      PMCID: PMC8039981     

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides.

Authors:  U Fuhrmann; E Bause; G Legler; H Ploegh
Journal:  Nature       Date:  1984 Feb 23-29       Impact factor: 49.962

3.  1-deoxynojirimycin impairs oligosaccharide processing of alpha 1-proteinase inhibitor and inhibits its secretion in primary cultures of rat hepatocytes.

Authors:  V Gross; T Andus; T A Tran-Thi; R T Schwarz; K Decker; P C Heinrich
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

4.  The effects of inhibitors of glucosidase I on the formation of Sindbis virus.

Authors:  S Schlesinger; A H Koyama; C Malfer; S L Gee; M J Schlesinger
Journal:  Virus Res       Date:  1985-03       Impact factor: 3.303

5.  Early and late functions associated with the Golgi apparatus reside in distinct compartments.

Authors:  W G Dunphy; E Fries; L J Urbani; J E Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  Monoclonal antibody against the carboxy terminal peptide of pp60src of Rous sarcoma virus reacts with native pp60src.

Authors:  T Tamura; H Bauer
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

7.  The carbohydrates of mouse hepatitis virus (MHV) A59: structures of the O-glycosidically linked oligosaccharides of glycoprotein E1.

Authors:  H Niemann; R Geyer; H D Klenk; D Linder; S Stirm; M Wirth
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

8.  Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion.

Authors:  A R Collins; R L Knobler; H Powell; M J Buchmeier
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

9.  Characterization of coronavirus II. Glycoproteins of the viral envelope: tryptic peptide analysis.

Authors:  L S Sturman; K V Holmes
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

10.  Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein.

Authors:  K V Holmes; E W Doller; L S Sturman
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

View more
  24 in total

1.  Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy.

Authors:  Benjamin W Neuman; Brian D Adair; Craig Yoshioka; Joel D Quispe; Gretchen Orca; Peter Kuhn; Ronald A Milligan; Mark Yeager; Michael J Buchmeier
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 2.  How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum.

Authors:  A Helenius
Journal:  Mol Biol Cell       Date:  1994-03       Impact factor: 4.138

3.  Fatty acid acylation of viral proteins in murine hepatitis virus-infected cells. Brief report.

Authors:  M F van Berlo; W J van den Brink; M C Horzinek; B A van der Zeijst
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Membrane integration and intracellular transport of the coronavirus glycoprotein E1, a class III membrane glycoprotein.

Authors:  T Mayer; T Tamura; M Falk; H Niemann
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

5.  Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus.

Authors:  K E Wright; R C Spiro; J W Burns; M J Buchmeier
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

6.  The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Authors:  P B Fischer; M Collin; G B Karlsson; W James; T D Butters; S J Davis; S Gordon; R A Dwek; F M Platt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

7.  Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses.

Authors:  Jinhong Chang; Lijuan Wang; Dongling Ma; Xiaowang Qu; Haitao Guo; Xiaodong Xu; Peter M Mason; Nigel Bourne; Robert Moriarty; Baohua Gu; Ju-Tao Guo; Timothy M Block
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

8.  Human small intestinal angiotensin-converting enzyme: intracellular transport, secretion and glycosylation.

Authors:  H Y Naim
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

9.  Inhibition of glycoprotein oligosaccharide processing in vitro and in influenza-virus-infected cells by alpha-D-mannopyranosylmethyl-p-nitrophenyltriazene.

Authors:  W McDowell; A Tlusty; R Rott; J N BeMiller; J A Bohn; R W Meyers; R T Schwarz
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

10.  Appropriate glycosylation of the fms gene product is a prerequisite for its transforming potency.

Authors:  A Hadwiger; H Niemann; A Käbisch; H Bauer; T Tamura
Journal:  EMBO J       Date:  1986-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.